Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Surgery may boost survival in rare artery disease

NCT ID NCT07149805

First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 30 times

Summary

This study looked at whether surgery helps people with Takayasu arteritis, a rare disease that narrows major arteries. Researchers compared 78 patients who had surgery to those who got only medical care. The goal was to see if surgery lowers the risk of death.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TAKAYASU ARTERITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If surgery proves better, it could guide doctors to recommend it more often for severe cases of Takayasu arteritis.

What could go wrong

This is a small, completed observational study, not a randomized trial. Results may not apply to all patients, and surgery carries its own risks.

Conditions

The condition(s) this trial relates to.

Takayasu arteritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.